Oncology Historical Income Statement
| TOI Stock | USD 0.15 0.01 6.25% |
Historical analysis of Oncology Institute income statement accounts such as Gross Profit of 45 M, Other Operating Expenses of 263.4 M, Cost Of Revenue of 181.5 M or Total Operating Expenses of 81.9 M can show how well Oncology Institute performed in making a profits. Evaluating Oncology Institute income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Oncology Institute's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Oncology Institute latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Oncology Institute is a good buy for the upcoming year.
Oncology |
About Oncology Income Statement Analysis
Oncology Institute Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Oncology Institute shareholders. The income statement also shows Oncology investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Oncology Institute Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Oncology Institute generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Oncology Institute minus its cost of goods sold. It is profit before Oncology Institute operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Oncology Institute. It is also known as Oncology Institute overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Oncology Institute's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Oncology Institute current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.As of now, Oncology Institute's Interest Expense is increasing as compared to previous years. The Oncology Institute's current Selling General Administrative is estimated to increase to about 121.1 M, while Tax Provision is forecasted to increase to (84.5 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 320K | 4.1M | 6.8M | 7.1M | Depreciation And Amortization | 3.3M | 4.4M | 5.9M | 3.8M |
Oncology Institute income statement Correlations
Click cells to compare fundamentals
Oncology Institute Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oncology Institute income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 1.4M | (492.8K) | (671K) | (243K) | (89K) | (84.6K) | |
| Net Interest Income | (3.4K) | (347.1K) | (320K) | (4.1M) | (7.3M) | (6.9M) | |
| Depreciation And Amortization | 2.9M | 3.2M | 3.3M | 4.4M | 5.9M | 3.8M | |
| Interest Expense | 3.4K | 347.1K | 320K | 4.1M | 6.8M | 7.1M | |
| Selling General Administrative | 29.6M | 309.2K | 484.2K | 119.7M | 115.3M | 121.1M | |
| Total Revenue | 155.4M | 187.5M | 203.0M | 252.5M | 324.2M | 226.6M | |
| Gross Profit | 29.9M | 36.9M | 40.8M | 52.1M | 59.6M | 45.0M | |
| Other Operating Expenses | 158.0M | 195.7M | 248.9M | 324.5M | 401.3M | 263.4M | |
| Operating Income | (2.6M) | (8.2M) | (45.9M) | (72.0M) | (77.0M) | (73.2M) | |
| Net Income From Continuing Ops | (4.0M) | (14.3M) | (8.3M) | 152K | (75.3M) | (71.6M) | |
| Ebit | (2.6M) | (14.5M) | (11.3M) | 4.0M | (76.3M) | (72.5M) | |
| Ebitda | 307.1K | (11.3M) | (7.9M) | 8.4M | (70.5M) | (66.9M) | |
| Cost Of Revenue | 125.5M | 150.6M | 162.2M | 200.4M | 264.7M | 181.5M | |
| Total Operating Expenses | 32.6M | 45.1M | 86.7M | 124.1M | 136.6M | 81.9M | |
| Reconciled Depreciation | 2.9M | 3.2M | 3.3M | 4.4M | 5.5M | 3.8M | |
| Income Before Tax | (2.6M) | (14.8M) | (11.6M) | 1.9M | (83.1M) | (78.9M) | |
| Total Other Income Expense Net | (3.4K) | (6.6M) | 34.3M | 81.9M | (6.1M) | (5.8M) | |
| Net Income Applicable To Common Shares | (4.0M) | (14.3M) | (8.3M) | 68K | 61.2K | 64.3K | |
| Net Income | (4.0M) | (14.3M) | (10.9M) | 1.7M | (83.1M) | (78.9M) | |
| Income Tax Expense | 1.4M | (492.8K) | (671K) | 247K | (36K) | (34.2K) |
Currently Active Assets on Macroaxis
When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.